Analysts think MURA stock price could increase by 365%
Jan 27, 2025, 12:25 PM
-6.08%
What does MURA do
Mural Oncology Plc is a clinical-stage company developing cytokine-based immunotherapies for cancer using its protein engineering platform. Its portfolio includes Nemvaleukin alfa and a tumor-targeted split IL-12 program.
5 analysts think MURA stock price will increase by 364.81%. The current median analyst target is $18.36 compared to a current stock price of $3.95. The lowest analysts target is $13.13 and the highest analyst target is $18.90.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
